查詢結果分析
相關文獻
- 提升婦癌病人化學治療品質及安全性
- 臺灣跨專業共識之化學治療安全作業指引
- 降低門診化學治療處方電腦輸入錯誤率專案
- 節拍式化學治療在婦科癌症的運用
- 提升手術團隊執行腹腔溫熱化療防護安全正確率
- 運用智慧輸液幫浦於化療之成效
- Successful Treatment of a Bulky Seminoma in an Abdominal Undescended Testis: A Case Report
- Ifosfamide-Based Chemotherapy for Previously Treated Lung Cancer Patients
- Treatment of Ultra-High Risk Gestational Trophoblastic Disease by an EMA/CE Regimen
- The Experience of Combination of Chemotherapy and Surgery in Treatment of Advanced Nonseminomatous Germ Cell Tumor of the Testis
頁籤選單縮合
| 題 名 | 提升婦癌病人化學治療品質及安全性=Enhancing the Quality and Safety of Chemotherapy for Patients with Gynecologic Cancer |
|---|---|
| 作 者 | 郭曉莉; 翁嘉穗; 張雅淳; | 書刊名 | 醫療品質雜誌 |
| 卷 期 | 20:1 2026.01[民115.01] |
| 頁 次 | 頁37-41 |
| 分類號 | 419.29 |
| 關鍵詞 | 化學治療; 婦科癌症; 跨專業團隊照護; 病人安全; Chemotherapy; Gynecologic cancer; Multidisciplinary care; Patient safety; |
| 語 文 | 中文(Chinese) |
| DOI | 10.53106/279013352026012001006 |
| 中文摘要 | 目的:本研究旨在評估導入跨專業團隊合作之團隊資源管理(Team Resource Management, TRM)照護模式,對提升婦癌病人化學治療照護品質及病人安全之成效。方法:針對首次接受化學治療之婦癌病人,導入以跨專業團隊合作為核心之TRM照護模式,由護理師、營養師及藥師等跨專業團隊成員提供專業照護與衛教資訊。病人返家後,透過婦癌照護員-婦癌人工智慧照護平台(連結Messenger)回報居家期間出現之症狀,以持續掌握病人近期治療相關副作用,並由個案管理師提供即時衛教與照護介入。結果:實際接受TRM照護計畫之婦癌病人比例達94.7%。病人於兩日內接受跨專業團隊提供之專業衛教比例達100%,平均衛教時間為63分鐘。病人返家後使用線上回報之比例為84.2%,有助於個案管理師更即時發現並處理病人照護問題。結論:導入以跨專業團隊合作為基礎之團隊資源管理照護模式,可提供更專業、即時且個別化之衛教與照護,進而提升婦癌病人化學治療之照護品質與病人安全。 |
| 英文摘要 | Purpose: This study examined the impact of implementing a multidisciplinary Team Resource Management (TRM) care model on quality and patient safety in chemotherapy care for patients with gynecologic cancer. Methods: A TRM-based care model was implemented for patients receiving chemotherapy for the first time. Multidisciplinary team members, including nurses, dietitians, and pharmacists, provided patients with profession-specific information. After discharge, patients reported symptoms experienced at home using an online platform linked to a messaging application, the Gynecologic Cancer Caregiver Artificial Intelligence Platform. The platform enabled continuous monitoring of recent treatment-related adverse effects and facilitated timely health education and care interventions by case managers. Results: The TRM care program was provided to 94.7% of patients receiving chemotherapy. Within two days, 100% of patients received profession-specific education from the multidisciplinary team, with an average education time of 63 minutes. After discharge, 84.2% of patients used the online side-effect reporting system, enabling case managers to identify patient concerns more promptly. Conclusion: A multidisciplinary TRM care model enabled the delivery of professional, timely, and personalized education, thereby improving chemotherapy care quality and patient safety for patients with gynecologic cancer. |
本系統中英文摘要資訊取自各篇刊載內容。